Description

The global cardiovascular devices market is expected to be 47.1 billion in 2021 and reach 72.28 billion in 2027, registering a CAGR of 7.40%, during the forecast period 2021-2027. Cardiovascular devices are the medical equipment, that is utilized to diagnose and cure heart disease and other heart-related problems. This equipment plays a vital role in the prevention and treatment of cardiovascular diseases. Among Americans, an average of one individual dies from cardiovascular disease every 40 seconds. As per the American College of Cardiology, cardiovascular disease (CVD) accounted for 8,00,000 deaths in the US in 2017. Cardiovascular diseases are the leading cause of death across the globe. The consistently rising global burden of cardiac disease-related deaths will continue to generate thriving demand for cardiovascular devices in the global market during the forecast period. During the global COVID-19 pandemic, the global cardiovascular devices market has been one of the worst-hit segments globally. Some of the world’s leaders in cardiovascular devices manufacturing, like Medtronic, have declared huge losses in their cardiology-related revenues through 2020 and are recovering now.

Key Dynamics Influencing Cardiovascular Devices Market

The prevalence of chronic heart diseases, rapidly rising rate of sedentary lifestyle adoption, especially due to the mushrooming work from home culture, unhealthy routine habits which include hypertension, smoking, consumption of alcohol, along with an increasing geriatric population, and technology advancement, key factors driving the growth of the market over the forecast period. On the diagnostic and monitoring front, a new generation of compact and portable EGC is boosting its high adoption, especially in the home healthcare segment. Further, with the introduction of wireless ECG, the doctor can diagnose and monitor the patient remotely on time, which further accelerating market growth. On the other hand, factors including high device maintenance cost, lack of skilled personnel, and strict regulatory product approval procedures are curbing the growth of the global cardiovascular device market in the upcoming years.

Impact of COVID-19 on Cardiovascular Devices Market

The outbreak of the COVID-19 pandemic has negatively impacted the global cardiovascular devices industry in more than one way. The production experienced quite a lasting, sudden plunge during the initial months of the pandemic-driven nationwide lockdowns. Sales were also on a heavy setback as a massive number of active procedures were delayed as they fell in the non-emergency category during the critical COVID-19 times. On the other hand, cardiovascular disease diagnostics also took a backseat due to inadequate resource availability dedicatedly serving in cardiology wards at hospitals. This is due to the reduction in cardiovascular disease diagnosis due to healthcare resources reserved for COVID-19 patients. During the beginning of the pandemic, regular check-ups and diagnoses have been postponed, and those experiencing cardiovascular symptoms are staying away from clinics and hospitals due to the fear of contracting COVID-19.

Scope of the Report

The report outlines the global Cardiovascular Devices market study based on device type and end-user.

Based on device type, the cardiovascular devices market is segmented into-

• Electrocardiography (ECG)
• Cardiac Catheter
• Heart Valve, Pacemaker
• Defibrillator
• Event Monitor
• Guidewire
• Others

Based on end-user, the cardiovascular devices market is segmented into-

• Cardiac Centers
• Ambulatory
• Surgery Centers
• Hospitals

Cardiovascular Devices Market Regional Outlook

The global cardiovascular device market is geographically segmented into North America, Asia Pacific, Europe, South America, and Middle East & Africa (MEA). North America is expected to dominate the global cardiovascular device market with the largest market share over the forecast period. The dominance of this region is majorly attributed to the increasing awareness about commercially available products, high adoption of advanced surgical treatment, presence of geriatric population, and sedentary lifestyle. Further, the rising adoption of home healthcare equipment as a result of government penalties enforced on hospitals for patient readmission is boosting the demand for monitoring and diagnostic cardiovascular systems enormously.

Asia Pacific is anticipated to register a healthy CAGR growth rate in the cardiovascular device market over the forecast period. This growth is attributed to the rising prevalence of cardiac disease. Various hospitals are investing to purchase the latest equipment; rising R&D activities to develop highly advanced cardiovascular devices are major factors boosting the market growth in the region. Further, the increasing medical tourism sector in the Asia Pacific is anticipated to propel the demand for cardiovascular systems, especially in India, China, Thailand, Japan, and Malaysia.

Competitive Landscape Analysis

The leading manufacturers of cardiovascular devices in the global market include Abbott Laboratories, Medtronic PLC, Boston Scientific Corporation, Cardinal Health Inc., Edward Lifesciences, and Biosense Webster, Inc. (Johnson & Johnson). Other cardiovascular device manufacturers include Cook Medical, Sahajanand Medical Technologies, Siemen AG, BD, General Electronic Company, B. Braun Melsungen AG, Koninklijke Philips N.V., St. Jude Medical, Inc., and Becton, Dickinson, and Company.

• In February 2019, Cook Medical received approval from U.S. Food and Drug Administration (FDA) for its Zenith endovascular aortic dissection system.
• In March 2018, Sahajanand Medical Technologies entered into a partnership with Cardinal Health to offer Cardinal Health access to the fast-growing Indian cardiology market.

The cardiovascular devices market report provides a thorough analysis of macro-economic factors along with the market attractiveness of every segment. The report will include an in-depth qualitative and quantitative assessment of the segmental/regional outlook with the market players in the respective segment and region/country. The information concluded in the report includes the inputs from industry participants and industry experts across the value chain.

Cardiovascular Devices Market Report Covers Comprehensive Analysis On

• Market Segmentation & Regional Analysis
• Market Size of 10 years
• Pricing Analysis
• Supply & Demand Analysis
• Product Life Cycle Analysis
• Porter's Five Forces & Value Chain Analysis
• Developed & Emerging Economies Analysis
• PEST Analysis
• Market and Forecast Factor Analysis
• Market Opportunities, Risks, & Trends
• Conclusion & Recommendation
• Regulatory Landscape
• Patent Analysis
• Competition Landscape
• 15+ Company Profiles

Cardiovascular Devices Market Regional Analysis Includes

• North America (US, Canada, Mexico)
• South America (Brazil, Argentina, Colombia, Peru, Rest of Latin America)
• Europe (Germany, Italy, France, UK, Spain, Poland, Russia, Slovenia, Slovakia, Hungary, Czech Republic, Belgium, the Netherlands, Norway, Sweden, Denmark, Rest of Europe)
• Asia Pacific (China, Japan, India, South Korea, Indonesia, Malaysia, Thailand, Vietnam, Myanmar, Cambodia, the Philippines, Singapore, Australia & New Zealand, Rest of Asia Pacific)
• The Middle East & Africa (Saudi Arabia, UAE, South Africa, Northern Africa, Rest of MEA

Cardiovascular Devices Market Target Audience

• Cardiovascular devices manufacture
• Cardiovascular devices distributors and raw material suppliers
• Tier 1 component suppliers
• Cardiovascular devices battery manufacturers
• Research institutions and universities
• Trade publications and magazines
• Government authorities, associations, and organizations
• Independent aftermarket players

Key Issues Addressed

• What is the market size by various segmentation of the cardiovascular devices by region and its respective countries?
• What are the customer buying behavior, key takeaways, and Porter's 5 forces of the cardiovascular devices market?
• What are the key opportunities and trends for manufacturers involved in the cardiovascular devices supply chain?
• What are the fundamental dynamics (drivers, restraints, opportunities, and challenges) of the market?
• What and how regulations, schemes, patents, and policies are impacting the growth of the market?
• What are the upcoming technological solutions influencing market trends? How will existing companies adapt to the new change in technology?
• What will be the impact of cutting-edge technology on the cardiovascular devices market?
• How COVID-19 impacted the demand and sales of cardiovascular devices in the global market? Also, the expected BPS drop or rise count of the market and market expected recovery period.
• Detailed analysis of the competitors and their latest launch, and what are the prominent startups introduced in the target market? Also, detailed company profiling of 25+ leading and prominent companies in the market.